This update is from yesterday morning and explains the price action:
Predictive Oncology Inc. (NASDAQ: POAI) gained 12.7% to $0.3105 in pre-market trading. Predictive Oncology recently reported collaboration with Integra Therapeutics to advance gene therapy.